Bristol-Myers Squibb (NYSE:BMY) Now Covered by Analysts at Piper Sandler

Piper Sandler started coverage on shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) in a report issued on Tuesday, MarketBeat.com reports. The firm issued an overweight rating and a $65.00 price target on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the stock. Truist Financial upped their price target on shares […]